0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Indocyanine Green Market Research Report 2026
Published Date: 2026-03-04
|
Report Code: QYRE-Auto-16O9200
Home | Market Reports
Global Indocyanine Green Market Insights and Forecast to 2028
BUY CHAPTERS

Global Indocyanine Green Market Research Report 2026

Code: QYRE-Auto-16O9200
Report
2026-03-04
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Indocyanine Green Market Size

The global Indocyanine Green market was valued at US$ 90.24 million in 2025 and is anticipated to reach US$ 126 million by 2032, at a CAGR of 5.0% from 2026 to 2032.

Indocyanine Green Market

Indocyanine Green Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Indocyanine Green competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Indocyanine green (ICG) (CAS 3599-32-4), a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.
Europe is the largest Indocyanine Green (CAS 3599-32-4) market with about 52% market share. USA is follower, accounting for about 22% market share.The key manufacturers are Pulsion Medical Systems AG,Dandong Yichuang Pharmaceutical, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical, Aurolab, Eisai, etc. Top 3 companies occupied about 60% market share.
Market drivers
Increasing demand for precision medicine
The popularization of fluorescence navigation technology in tumor surgery (such as da Vinci robotic surgery) has made ICG a key reagent for intraoperative imaging. High-incidence tumors such as liver cancer and breast cancer have driven demand (China has more than 400,000 new cases of liver cancer each year).
Technology upgrade and expansion of indications
ICG combined with near-infrared imaging (NIR) technology has been expanded to new scenarios such as lymphangiography and gastrointestinal anastomosis. Nanocarrier technology improves ICG stability and prolongs imaging time (such as tumor-targeted ICG nanoformulations).
Popularization of minimally invasive surgery
The proportion of minimally invasive surgeries such as laparoscopy and thoracoscopy has increased, and the demand for ICG imaging has surged.
This report delivers a comprehensive overview of the global Indocyanine Green market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Indocyanine Green. The Indocyanine Green market size, estimates, and forecasts are provided in terms of sales volume (K NOS) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Indocyanine Green market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Indocyanine Green manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Indocyanine Green Market Report

Report Metric Details
Report Name Indocyanine Green Market
Accounted market size in 2025 US$ 90.24 million
Forecasted market size in 2032 US$ 126 million
CAGR 5.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 25mg
  • 50mg
by Application
  • Ophthalmology
  • Neurosurgery
  • Liver Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pulsion Medical Systems AG, Dandong Yichuang Pharmaceutical, Daiichi Sankyo Company, SERB, Santen Pharmaceutical, Diagnostic Green, McKesson Corp, OriFarm, Jeil Pharmaceutical, Aurolab, Cellbion, Eisai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Indocyanine Green manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Indocyanine Green sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Indocyanine Green Market growing?

Ans: The Indocyanine Green Market witnessing a CAGR of 5.0% during the forecast period 2026-2032.

What is the Indocyanine Green Market size in 2032?

Ans: The Indocyanine Green Market size in 2032 will be US$ 126 million.

What is the Indocyanine Green Market share by region?

Ans: Europe is the largest Indocyanine Green (CAS 3599-32-4) market with about 52% market share. USA is follower, accounting for about 22% market share.

What is the market share of major companies in Indocyanine Green Market?

Ans: Top 3 companies occupied about 60% market share.

Who are the main players in the Indocyanine Green Market report?

Ans: The main players in the Indocyanine Green Market are Pulsion Medical Systems AG, Dandong Yichuang Pharmaceutical, Daiichi Sankyo Company, SERB, Santen Pharmaceutical, Diagnostic Green, McKesson Corp, OriFarm, Jeil Pharmaceutical, Aurolab, Cellbion, Eisai

What are the Application segmentation covered in the Indocyanine Green Market report?

Ans: The Applications covered in the Indocyanine Green Market report are Ophthalmology, Neurosurgery, Liver Diseases, Others

What are the Type segmentation covered in the Indocyanine Green Market report?

Ans: The Types covered in the Indocyanine Green Market report are 25mg, 50mg

1 Indocyanine Green Market Overview
1.1 Product Definition
1.2 Indocyanine Green by Type
1.2.1 Global Indocyanine Green Market Value by Type: 2025 vs 2032
1.2.2 25mg
1.2.3 50mg
1.3 Indocyanine Green by Application
1.3.1 Global Indocyanine Green Market Value by Application: 2025 vs 2032
1.3.2 Ophthalmology
1.3.3 Neurosurgery
1.3.4 Liver Diseases
1.3.5 Others
1.4 Global Indocyanine Green Market Size Estimates and Forecasts
1.4.1 Global Indocyanine Green Revenue 2021–2032
1.4.2 Global Indocyanine Green Sales 2021–2032
1.4.3 Global Indocyanine Green Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Indocyanine Green Market Competition by Manufacturers
2.1 Global Indocyanine Green Sales Market Share by Manufacturers (2021–2026)
2.2 Global Indocyanine Green Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Indocyanine Green Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Indocyanine Green, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Indocyanine Green, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Indocyanine Green, Product Types and Applications
2.7 Global Key Manufacturers of Indocyanine Green, Date of Entry into the Industry
2.8 Global Indocyanine Green Market Competitive Situation and Trends
2.8.1 Global Indocyanine Green Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Indocyanine Green Players Market Share by Revenue
2.8.3 Global Indocyanine Green Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Indocyanine Green Market Scenario by Region
3.1 Global Indocyanine Green Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Indocyanine Green Sales by Region: 2021–2032
3.2.1 Global Indocyanine Green Sales by Region: 2021–2026
3.2.2 Global Indocyanine Green Sales by Region: 2027–2032
3.3 Global Indocyanine Green Revenue by Region: 2021–2032
3.3.1 Global Indocyanine Green Revenue by Region: 2021–2026
3.3.2 Global Indocyanine Green Revenue by Region: 2027–2032
3.4 North America Indocyanine Green Market Facts & Figures by Country
3.4.1 North America Indocyanine Green Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Indocyanine Green Sales by Country (2021–2032)
3.4.3 North America Indocyanine Green Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Indocyanine Green Market Facts & Figures by Country
3.5.1 Europe Indocyanine Green Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Indocyanine Green Sales by Country (2021–2032)
3.5.3 Europe Indocyanine Green Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Indocyanine Green Market Facts & Figures by Region
3.6.1 Asia Pacific Indocyanine Green Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Indocyanine Green Sales by Region (2021–2032)
3.6.3 Asia Pacific Indocyanine Green Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Indocyanine Green Market Facts & Figures by Country
3.7.1 Latin America Indocyanine Green Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Indocyanine Green Sales by Country (2021–2032)
3.7.3 Latin America Indocyanine Green Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Indocyanine Green Market Facts & Figures by Country
3.8.1 Middle East and Africa Indocyanine Green Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Indocyanine Green Sales by Country (2021–2032)
3.8.3 Middle East and Africa Indocyanine Green Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Indocyanine Green Sales by Type (2021–2032)
4.1.1 Global Indocyanine Green Sales by Type (2021–2026)
4.1.2 Global Indocyanine Green Sales by Type (2027–2032)
4.1.3 Global Indocyanine Green Sales Market Share by Type (2021–2032)
4.2 Global Indocyanine Green Revenue by Type (2021–2032)
4.2.1 Global Indocyanine Green Revenue by Type (2021–2026)
4.2.2 Global Indocyanine Green Revenue by Type (2027–2032)
4.2.3 Global Indocyanine Green Revenue Market Share by Type (2021–2032)
4.3 Global Indocyanine Green Price by Type (2021–2032)
5 Segment by Application
5.1 Global Indocyanine Green Sales by Application (2021–2032)
5.1.1 Global Indocyanine Green Sales by Application (2021–2026)
5.1.2 Global Indocyanine Green Sales by Application (2027–2032)
5.1.3 Global Indocyanine Green Sales Market Share by Application (2021–2032)
5.2 Global Indocyanine Green Revenue by Application (2021–2032)
5.2.1 Global Indocyanine Green Revenue by Application (2021–2026)
5.2.2 Global Indocyanine Green Revenue by Application (2027–2032)
5.2.3 Global Indocyanine Green Revenue Market Share by Application (2021–2032)
5.3 Global Indocyanine Green Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pulsion Medical Systems AG
6.1.1 Pulsion Medical Systems AG Company Information
6.1.2 Pulsion Medical Systems AG Description and Business Overview
6.1.3 Pulsion Medical Systems AG Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pulsion Medical Systems AG Indocyanine Green Product Portfolio
6.1.5 Pulsion Medical Systems AG Recent Developments/Updates
6.2 Dandong Yichuang Pharmaceutical
6.2.1 Dandong Yichuang Pharmaceutical Company Information
6.2.2 Dandong Yichuang Pharmaceutical Description and Business Overview
6.2.3 Dandong Yichuang Pharmaceutical Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Dandong Yichuang Pharmaceutical Indocyanine Green Product Portfolio
6.2.5 Dandong Yichuang Pharmaceutical Recent Developments/Updates
6.3 Daiichi Sankyo Company
6.3.1 Daiichi Sankyo Company Company Information
6.3.2 Daiichi Sankyo Company Description and Business Overview
6.3.3 Daiichi Sankyo Company Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Daiichi Sankyo Company Indocyanine Green Product Portfolio
6.3.5 Daiichi Sankyo Company Recent Developments/Updates
6.4 SERB
6.4.1 SERB Company Information
6.4.2 SERB Description and Business Overview
6.4.3 SERB Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 SERB Indocyanine Green Product Portfolio
6.4.5 SERB Recent Developments/Updates
6.5 Santen Pharmaceutical
6.5.1 Santen Pharmaceutical Company Information
6.5.2 Santen Pharmaceutical Description and Business Overview
6.5.3 Santen Pharmaceutical Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Santen Pharmaceutical Indocyanine Green Product Portfolio
6.5.5 Santen Pharmaceutical Recent Developments/Updates
6.6 Diagnostic Green
6.6.1 Diagnostic Green Company Information
6.6.2 Diagnostic Green Description and Business Overview
6.6.3 Diagnostic Green Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Diagnostic Green Indocyanine Green Product Portfolio
6.6.5 Diagnostic Green Recent Developments/Updates
6.7 McKesson Corp
6.7.1 McKesson Corp Company Information
6.7.2 McKesson Corp Description and Business Overview
6.7.3 McKesson Corp Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 McKesson Corp Indocyanine Green Product Portfolio
6.7.5 McKesson Corp Recent Developments/Updates
6.8 OriFarm
6.8.1 OriFarm Company Information
6.8.2 OriFarm Description and Business Overview
6.8.3 OriFarm Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 OriFarm Indocyanine Green Product Portfolio
6.8.5 OriFarm Recent Developments/Updates
6.9 Jeil Pharmaceutical
6.9.1 Jeil Pharmaceutical Company Information
6.9.2 Jeil Pharmaceutical Description and Business Overview
6.9.3 Jeil Pharmaceutical Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jeil Pharmaceutical Indocyanine Green Product Portfolio
6.9.5 Jeil Pharmaceutical Recent Developments/Updates
6.10 Aurolab
6.10.1 Aurolab Company Information
6.10.2 Aurolab Description and Business Overview
6.10.3 Aurolab Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Aurolab Indocyanine Green Product Portfolio
6.10.5 Aurolab Recent Developments/Updates
6.11 Cellbion
6.11.1 Cellbion Company Information
6.11.2 Cellbion Description and Business Overview
6.11.3 Cellbion Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Cellbion Indocyanine Green Product Portfolio
6.11.5 Cellbion Recent Developments/Updates
6.12 Eisai
6.12.1 Eisai Company Information
6.12.2 Eisai Description and Business Overview
6.12.3 Eisai Indocyanine Green Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Eisai Indocyanine Green Product Portfolio
6.12.5 Eisai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Indocyanine Green Industry Chain Analysis
7.2 Indocyanine Green Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Indocyanine Green Production Mode & Process Analysis
7.4 Indocyanine Green Sales and Marketing
7.4.1 Indocyanine Green Sales Channels
7.4.2 Indocyanine Green Distributors
7.5 Indocyanine Green Customer Analysis
8 Indocyanine Green Market Dynamics
8.1 Indocyanine Green Industry Trends
8.2 Indocyanine Green Market Drivers
8.3 Indocyanine Green Market Challenges
8.4 Indocyanine Green Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Indocyanine Green Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Indocyanine Green Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Indocyanine Green Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Indocyanine Green Sales (K NOS) of Key Manufacturers (2021–2026)
 Table 5. Global Indocyanine Green Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Indocyanine Green Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Indocyanine Green Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Indocyanine Green Average Price (USD/NOS) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Indocyanine Green, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Indocyanine Green, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Indocyanine Green, Product Types and Applications
 Table 12. Global Key Manufacturers of Indocyanine Green, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Indocyanine Green Companies by Tier (Tier 1, Tier 2, Tier 3), based on Indocyanine Green Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Indocyanine Green Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Indocyanine Green Sales by Region (K NOS), 2021–2026
 Table 18. Global Indocyanine Green Sales Market Share by Region (2021–2026)
 Table 19. Global Indocyanine Green Sales by Region (K NOS), 2027–2032
 Table 20. Global Indocyanine Green Sales Market Share by Region (2027–2032)
 Table 21. Global Indocyanine Green Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Indocyanine Green Revenue Market Share by Region (2021–2026)
 Table 23. Global Indocyanine Green Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Indocyanine Green Revenue Market Share by Region (2027–2032)
 Table 25. North America Indocyanine Green Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Indocyanine Green Sales by Country (K NOS), 2021–2026
 Table 27. North America Indocyanine Green Sales by Country (K NOS), 2027–2032
 Table 28. North America Indocyanine Green Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Indocyanine Green Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Indocyanine Green Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Indocyanine Green Sales by Country (K NOS), 2021–2026
 Table 32. Europe Indocyanine Green Sales by Country (K NOS), 2027–2032
 Table 33. Europe Indocyanine Green Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Indocyanine Green Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Indocyanine Green Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Indocyanine Green Sales by Region (K NOS), 2021–2026
 Table 37. Asia Pacific Indocyanine Green Sales by Region (K NOS), 2027–2032
 Table 38. Asia Pacific Indocyanine Green Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Indocyanine Green Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Indocyanine Green Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Indocyanine Green Sales by Country (K NOS), 2021–2026
 Table 42. Latin America Indocyanine Green Sales by Country (K NOS), 2027–2032
 Table 43. Latin America Indocyanine Green Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Indocyanine Green Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Indocyanine Green Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Indocyanine Green Sales by Country (K NOS), 2021–2026
 Table 47. Middle East and Africa Indocyanine Green Sales by Country (K NOS), 2027–2032
 Table 48. Middle East and Africa Indocyanine Green Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Indocyanine Green Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Indocyanine Green Sales (K NOS) by Type (2021–2026)
 Table 51. Global Indocyanine Green Sales (K NOS) by Type (2027–2032)
 Table 52. Global Indocyanine Green Sales Market Share by Type (2021–2026)
 Table 53. Global Indocyanine Green Sales Market Share by Type (2027–2032)
 Table 54. Global Indocyanine Green Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Indocyanine Green Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Indocyanine Green Revenue Market Share by Type (2021–2026)
 Table 57. Global Indocyanine Green Revenue Market Share by Type (2027–2032)
 Table 58. Global Indocyanine Green Price (USD/NOS) by Type (2021–2026)
 Table 59. Global Indocyanine Green Price (USD/NOS) by Type (2027–2032)
 Table 60. Global Indocyanine Green Sales (K NOS) by Application (2021–2026)
 Table 61. Global Indocyanine Green Sales (K NOS) by Application (2027–2032)
 Table 62. Global Indocyanine Green Sales Market Share by Application (2021–2026)
 Table 63. Global Indocyanine Green Sales Market Share by Application (2027–2032)
 Table 64. Global Indocyanine Green Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Indocyanine Green Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Indocyanine Green Revenue Market Share by Application (2021–2026)
 Table 67. Global Indocyanine Green Revenue Market Share by Application (2027–2032)
 Table 68. Global Indocyanine Green Price (USD/NOS) by Application (2021–2026)
 Table 69. Global Indocyanine Green Price (USD/NOS) by Application (2027–2032)
 Table 70. Pulsion Medical Systems AG Company Information
 Table 71. Pulsion Medical Systems AG Description and Business Overview
 Table 72. Pulsion Medical Systems AG Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 73. Pulsion Medical Systems AG Indocyanine Green Product
 Table 74. Pulsion Medical Systems AG Recent Developments/Updates
 Table 75. Dandong Yichuang Pharmaceutical Company Information
 Table 76. Dandong Yichuang Pharmaceutical Description and Business Overview
 Table 77. Dandong Yichuang Pharmaceutical Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 78. Dandong Yichuang Pharmaceutical Indocyanine Green Product
 Table 79. Dandong Yichuang Pharmaceutical Recent Developments/Updates
 Table 80. Daiichi Sankyo Company Company Information
 Table 81. Daiichi Sankyo Company Description and Business Overview
 Table 82. Daiichi Sankyo Company Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 83. Daiichi Sankyo Company Indocyanine Green Product
 Table 84. Daiichi Sankyo Company Recent Developments/Updates
 Table 85. SERB Company Information
 Table 86. SERB Description and Business Overview
 Table 87. SERB Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 88. SERB Indocyanine Green Product
 Table 89. SERB Recent Developments/Updates
 Table 90. Santen Pharmaceutical Company Information
 Table 91. Santen Pharmaceutical Description and Business Overview
 Table 92. Santen Pharmaceutical Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 93. Santen Pharmaceutical Indocyanine Green Product
 Table 94. Santen Pharmaceutical Recent Developments/Updates
 Table 95. Diagnostic Green Company Information
 Table 96. Diagnostic Green Description and Business Overview
 Table 97. Diagnostic Green Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 98. Diagnostic Green Indocyanine Green Product
 Table 99. Diagnostic Green Recent Developments/Updates
 Table 100. McKesson Corp Company Information
 Table 101. McKesson Corp Description and Business Overview
 Table 102. McKesson Corp Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 103. McKesson Corp Indocyanine Green Product
 Table 104. McKesson Corp Recent Developments/Updates
 Table 105. OriFarm Company Information
 Table 106. OriFarm Description and Business Overview
 Table 107. OriFarm Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 108. OriFarm Indocyanine Green Product
 Table 109. OriFarm Recent Developments/Updates
 Table 110. Jeil Pharmaceutical Company Information
 Table 111. Jeil Pharmaceutical Description and Business Overview
 Table 112. Jeil Pharmaceutical Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 113. Jeil Pharmaceutical Indocyanine Green Product
 Table 114. Jeil Pharmaceutical Recent Developments/Updates
 Table 115. Aurolab Company Information
 Table 116. Aurolab Description and Business Overview
 Table 117. Aurolab Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 118. Aurolab Indocyanine Green Product
 Table 119. Aurolab Recent Developments/Updates
 Table 120. Cellbion Company Information
 Table 121. Cellbion Description and Business Overview
 Table 122. Cellbion Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 123. Cellbion Indocyanine Green Product
 Table 124. Cellbion Recent Developments/Updates
 Table 125. Eisai Company Information
 Table 126. Eisai Description and Business Overview
 Table 127. Eisai Indocyanine Green Sales (K NOS), Revenue (US$ Million), Price (USD/NOS), and Gross Margin (2021–2026)
 Table 128. Eisai Indocyanine Green Product
 Table 129. Eisai Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Indocyanine Green Distributors List
 Table 133. Indocyanine Green Customers List
 Table 134. Indocyanine Green Market Trends
 Table 135. Indocyanine Green Market Drivers
 Table 136. Indocyanine Green Market Challenges
 Table 137. Indocyanine Green Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Indocyanine Green
 Figure 2. Global Indocyanine Green Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Indocyanine Green Market Share by Type: 2025 & 2032
 Figure 4. 25mg Product Picture
 Figure 5. 50mg Product Picture
 Figure 6. Global Indocyanine Green Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Indocyanine Green Market Share by Application: 2025 & 2032
 Figure 8. Ophthalmology
 Figure 9. Neurosurgery
 Figure 10. Liver Diseases
 Figure 11. Others
 Figure 12. Global Indocyanine Green Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Indocyanine Green Market Size (US$ Million), 2021–2032
 Figure 14. Global Indocyanine Green Sales (K NOS), 2021–2032
 Figure 15. Global Indocyanine Green Average Price (USD/NOS), 2021–2032
 Figure 16. Indocyanine Green Report Years Considered
 Figure 17. Indocyanine Green Sales Share by Manufacturers in 2025
 Figure 18. Global Indocyanine Green Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Indocyanine Green Players: Market Share by Revenue in Indocyanine Green in 2025
 Figure 20. Indocyanine Green Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Indocyanine Green Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Indocyanine Green Sales Market Share by Country (2021–2032)
 Figure 23. North America Indocyanine Green Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Indocyanine Green Sales Market Share by Country (2021–2032)
 Figure 27. Europe Indocyanine Green Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Indocyanine Green Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Indocyanine Green Revenue Market Share by Region (2021–2032)
 Figure 35. China Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Indocyanine Green Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Indocyanine Green Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Indocyanine Green Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Indocyanine Green Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Indocyanine Green Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Indocyanine Green by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Indocyanine Green by Type (2021–2032)
 Figure 56. Global Indocyanine Green Price (USD/NOS) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Indocyanine Green by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Indocyanine Green by Application (2021–2032)
 Figure 59. Global Indocyanine Green Price (USD/NOS) by Application (2021–2032)
 Figure 60. Indocyanine Green Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String